作者: Charles T. Dotter , Josef Rösch , Arthur J. Seaman , Daniel Dennis , William H. Massey
DOI: 10.1148/102.2.283
关键词:
摘要: Abstract Seventeen patients were treated with streptokinase for thromboembolic disorders. This material appears to offer an improvement in therapy selected cases. Fibrinolytic seems be of greatest value fresh clots; it is ineffective the presence clot organization. Further trial, including exploration possible use selective lysis, warranted.